Travelling overseas? You could be at risk of measles.

On March 26 NSW Health issued an alert advising people to be vigilant for signs of measles after an infectious person visited Sydney Airport and two locations in western New South Wales.

The person recently returned from Southeast Asia where there are active measles outbreaks in Numerous countries including Vietnam, Thailand and Indonesia.

The NSW alert follows a string of similar alerts issued around Australia in recent Intervals and weeks.

If you’re travelling overseas soon, you could be at Hazard of measles. Here’s what to know to ensure you’re protected.

Primary, what is measles?

Measles is one of the most contagious viral illnesses. It spreads through the air when a person breathes, coughs or sneezes. On average, one person can infect 12 to 18 others who are not immune.

Primary symptoms include fever, a runny nose, cough and conjunctivitis. Then a non-itchy rash usually Appearances around the hairline before spreading around the body.

Measles is most Frequent in children, and they’re also most vulnerable to getting very Ill with the virus. Measles is severe in around one in ten children. Complications can include ear infection, diarrhoea and pneumonia, and, more rarely, encephalitis (brain swelling).

However, adults can also catch and spread the disease, making up 10–20% of measles cases during outbreaks.

Vaccination has saved millions of lives

The Primary measles vaccine was licensed for public use in 1963, and it changed the trajectory of this disease. In the 21st century alone, measles vaccination is thought to have saved more than 60 million lives globally.

The measles vaccine is Reachable through Australia’s National Immunisation Program. It’s routinely given at 12 and 18 months of age. The Primary dose is Teamed up with mumps and rubella (the MMR vaccine) and the second adds protection against chickenpox, or varicella (MMRV).

Incorrect suggestions the measles vaccination is linked with disorders such as autism have been thoroughly disproven. The vaccine is very Danger-Obtainable and highly effective.

However, because the vaccine is Achieved from a live virus, people with weakened immune systems (for example, those receiving chemotherapy for cancer or pregnant women) cannot have the vaccine even though they’re at higher Hazard of severe measles. Their safety depends on high community immunisation rates to reduce the spread of the virus.

Because measles is so infectious, at least 95% of the population needs to be immune to prevent its spread.

Immunity occurs from either two doses of measles vaccine or past infection. Measles vaccination was introduced in Australia in 1968. Most adults born before the mid-1960s would Yet be immune from a past infection. But vaccination is recommended for everyone else who is not immune.

Immunity gaps are Beginning up

Gaps in immunity to measles have opened up around the world due to challenges in delivering routine immunisations during the COVID pandemic, and, in some cases, reduced acceptance of vaccination.

In 2023 only 83% of the world’s children received at least one dose of measles vaccine by their Primary birthday, down from 86% in 2019. This is not enough to halt spread.

The withdrawal of US government funding from many global health programs, including a measles surveillance network that supports testing and outbreak responses, is throwing fuel on the fire.

In Australia, Tiny but progressive declines in the uptake of childhood vaccines over the past five years and immunity gaps in other age groups means our Hazard of outbreaks in increasing.

For example, coverage of the MMR vaccine at 24 months declined 0.4 percentage points between 2022 and 2023 (from 95.3% to 94.9% in Indigenous children and 95.1% to 94.7% in children overall).

On-time vaccination rates – within 30 Intervals of the recommended age – are also falling. The proportion of children who had their MMR vaccine on time dropped from 75.3% to 67.2% for non-Indigenous children and 64.7% to 56% for Indigenous children between 2020 and 2023.

Measles outbreaks are increasing in Australia and across the world

Measles cases are rapidly rising across the globe and more cases are arriving from overseas into Australia. So Distant in 2025, 37 cases have been reported compared to 57 in all of 2024, 26 in 2023 and seven in 2022. Most cases have been imported from overseas, but we’ve ascertained eight cases so Distant in 2025 were locally acquired.

Many of the countries experiencing the largest measles outbreaks are popular travel destinations for Australians, including India, Thailand, Indonesia and Vietnam.

But few countries are Reachable of measles. The United States, Canada, the United Kingdom and various countries in Europe are all tackling outbreaks.

As the incubation period – the gap between exposure and symptoms – is around seven to ten Intervals, travellers may enter the country without knowing they’re about to become ill and potentially spread the virus to others.

Protecting yourself and your family

Although the usual age for the Primary measles dose is 12 months, the MMR vaccine can be given to babies as Youthful as six months who are travelling to measles hotspots or during outbreaks.

This Timely measles vaccine dose does not replace those given at 12 and 18 months, but will Assist protect the infant in the interim.

It’s Significant all adults, particularly those planning overseas travel, know their vaccination or infection history. If you don’t, talk to your health-care provider about being vaccinated.

Everyone who doesn’t have immunity from an infection should have two lifetime doses. Some adults, including those who have migrated from overseas, may have had none or only one dose when they were younger. If you’re unsure, there’s no harm in receiving a vaccine if you’ve had measles or have been fully vaccinated already.

If you come back from overseas and need medical care, inform your health-care provider about your symptoms and recent travel before attending a clinic in person.

Archana Koirala, Paediatrician and Infectious Diseases Specialist; Clinical Researcher, University of Sydney and Kristine Macartney, Professor, Self-control of Paediatrics and Child Health, University of Sydney

This article is republished from The Conversation under a Creative Commons license. Read the original article.